Bronx, NY 10451-10499 - http://www.bronx.com/news
FDA Approves MiddleBrook's Amoxicillin Drug For Strep Throat
http://www.bronx.com/news/articles/61/1/FDA-Approves-MiddleBrooks-Amoxicillin-Drug-For-Strep-Throat/Page1.html
Maria Milosheva
I was born, raised and currently live in Sofia, Bulgaria, EU. I am a journalist by profession and practice psychology for the past few years.

I started drawing in 1991, urged by strong inner need to recreate the reality beyond the usual – the world of forms and details… I have taken part in various exhibitions and my work is in a number of private collections. It can be seen at MarmiArt.com.

My drawings are created using mixed techniques – aquarelle, tempera, ink, pencils, etc. They are unique and have no names. Their eventual owners would give them names, effectively becoming a part of the process of creating them. Every one can charge their own drawing with one's own energy and identify it with one's self. Your drawing will repay generously, giving calm moments for reflection and meditation.

 
By Maria Milosheva
Published on 01/25/2008
 
Federal regulators have approved MiddleBrook Pharmaceuticals’ amoxicillin treatment for strep throat, capping eight years of ups and downs that nearly sank the company.

Federal regulators have approved MiddleBrook Pharmaceuticals’ amoxicillin treatment for strep throat, capping eight years of ups and downs that nearly sank the company.
 
The approval of Moxatag for adolescents and adults, which could shift how one of the more commonly prescribed antibiotics is used, is a win not only for the Germantown company but also for the Maryland biotechnology industry, which has had few products reach the market in recent years despite spending heavily on research.

The U.S. Food and Drug Administration's approval means that patients need to take only one Moxatag pill a day to get rid of the bacteria responsible for strep throat, compared with the traditional antibiotic, penicillin, taken four times a day, both over a period of 10 days.

- Pravda.ru